Patients who have metastatic renal cell carcinoma with sarcomatoid differentiation in the primary tumor have an increased risk for death following cytoreductive nephrectomy, study found.
Increased age was significantly associated with increased odds of a decline in Sexual Health Inventory for Men category, a study found.
In a small series, overall and disease-free survival rates were favorable.
Upfront cytoreductive nephrectomy for mRCC patients with certain clinical characteristics may enable them to defer systemic therapy for a prolonged interval.
Men who had ever used spironolactone had decreased odds of prostate cancer compared with never-users, according to a study.
In a study of men on active surveillance for low-risk prostate cancer, multiparametric magnetic resonance imaging by itself missed about one-fifth of men who had pathologic upgrading on subsequent biopsies.
A new analysis looking at the effect of PSA screening on prostate cancer mortality over a 25-year period found a more favorable balance of benefits and harms than the 16-year estimates from the European Randomized Study of Screening for Prostate Cancer.
Three major medical organizations have issued recommendations for the diagnosis and treatment of advanced prostate cancer, including metastatic hormone-sensitive disease and nonmetastatic and metastatic castration-resistant disease.